Introduction {#s1}
============

Chromosomal abnormalities occur in 1 of 160 live births [@pone.0027835-Driscoll1].The risk of giving birth to a child with chromosomal abnormalities, especially Down syndrome (OMIM\# 190685), increases throughout a woman\'s reproductive years [@pone.0027835-Hook1], [@pone.0027835-Morris1]. Prenatal diagnosis of fetal chromosomal abnormalities is the most common indication for invasive prenatal testing. The prevalence of chromosomal abnormalities in fetuses with aneuploidy accounts for 6--11% of all stillbirths and neonatal deaths [@pone.0027835-Wapner1], [@pone.0027835-Korteweg1]. Consequently, screening and diagnostic programs to detect the most common trisomies in live born infants are well established [@pone.0027835-Irving1]. Currently, G-band karyotyping and several molecular genetic methods including multiplex ligation-dependent probe amplification (MLPA), fluorescence in situ hybridization (FISH), quantitative fluorescent PCR (QF-PCR) and microarray-based comparative genomic hybridization (arrayCGH) have been well established for prenatal diagnosis of chromosomal abnormalities in clinical labs [@pone.0027835-Williams1], [@pone.0027835-Leung1]. Although these testing methods have been proved to be highly reliable, the major limitation remains restricted resolution or can only achieve limited coverage on the human genome at one time [@pone.0027835-Vermeesch1], [@pone.0027835-ACOG1].

To overcome these limitations, in this study we have developed a new method based on massively parallel sequencing (MPS) platform to detect fetal chromosomal abnormalities, which is independent of particular genetic markers and cell culture in medical practice. We directly sequenced 62 DNA samples extracted from uncultured amniotic fluid (AF) of pregnant women. After statistical analysis, we can clearly detect numerical chromosomal abnormalities among 46 chromosomes. The whole process only takes 7 days and the results were validated by full karyotyping analysis. Subsequently, we investigated the presence of copy number variations among 5 prenatal samples previously identified by arrayCGH. We demonstrated that with different whole genome sequencing coverage MPS platform could be applied for identification of aneuploidy and imbalanced chromosomal arrangements, and those approaches are more sensitive and effective compared with conventional methods.

Results {#s2}
=======

Detection of Fetal Aneuploidy {#s2a}
-----------------------------

In this study, the 32 test cases were used for sequencing analysis under double-blind conditions. For all 62 AF samples (30 normal controls and 32 test cases), we obtained 0.55∼3.28 million 35-bp single-end reads (or 19.25 Mb∼114.80 Mb sequencing data) which corresponds to 0.006∼0.038× human genome depth. Consequently, 0.20∼1.15 million unique reads (UR) were obtained for each sample ([Table 1](#pone-0027835-t001){ref-type="table"}). For each chromosome, the number of unique reads was counted and the UR% was calculated. The complete set of UR% for 62 samples is listed in [Table S1](#pone.0027835.s001){ref-type="supplementary-material"}. UR% for Chromosome X, Y also showed in [Fig. 1](#pone-0027835-g001){ref-type="fig"}. The gender of each sample can be determined from UR% of Chromosome X, Y. For 30 normal control samples, the mean and standard deviation (SD) of UR% for each chromosome were calculated. Then the *z-scores* of each of the chromosomes, except the Y chromosome, for each of the normal controls and test cases were calculated according to the formula described in [*Materials and methods*](#s4){ref-type="sec"} ([Table S2](#pone.0027835.s002){ref-type="supplementary-material"}). From 32 test cases, 5 cases had a z-score\>20 for chromosome 18 (indicating Trisomy 18), 6 cases had a z-score\>20 for chromosome 21 (indicating Trisomy 21), and 2 cases had a z-score←20 for chromosome X (indicating XO). All the other chromosomes had z-scores within ±3 for all 32 test cases (indicating euploid chromosomes) ([Fig. 2](#pone-0027835-g002){ref-type="fig"}, [Table. S1](#pone.0027835.s001){ref-type="supplementary-material"}). The detection of fetal aneuploidy based on sequencing analysis agreed with karyotyping results.

![UR-X% and UR-Y% of 62 amniotic fluid samples.](pone.0027835.g001){#pone-0027835-g001}

![z-scores of 62 AF samples for chromosome 21,18 and X determined by MPS.\
Broken lines indicate the z score cut-off value of ±3 for trisomy 21 and trisomy 18. All 11 trisomy cases have a z-score value greater than 3 and the 2 cases of Tuner syndrome have a z-score value less than minus 3.](pone.0027835.g002){#pone-0027835-g002}
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###### Raw data and UR% of chromosome 21, 18, 13, X, Y of 62 AF sample.

![](pone.0027835.t001){#pone-0027835-t001-1}

  Sample No.    Labrary No.   Fetal Karyotype   DNA Amount (ng)   Raw Data (reads)   Unique Data (reads)   UR-21%    UR-18%    UR-13%     UR-X%     UR-Y%
  ------------ ------------- ----------------- ----------------- ------------------ --------------------- --------- --------- --------- --------- ---------
  1                92H13           46XX               100            1 387 306             531 327         1.26909   2.91948   3.68963   4.22414   0.00320
  2                08H9            46XX               100            1 649 958             622 928         1.26638   2.90997   3.64248   4.22633   0.00385
  3                09H10           46XY               100            1 474 317             552 990         1.29496   3.05087   3.91725   2.16279   0.12586
  4                10H11           46XY               100            1 501 313             577 494         1.29664   2.98046   3.74255   2.12764   0.12295
  5                11H12           46XX               100            1 341 688             514 366         1.26525   2.96754   3.68026   4.18671   0.00447
  6                12H14           46XY               100            1 315 342             502 804         1.26968   3.02663   3.77026   2.15392   0.11913
  7                13H15           46XX               100            1 520 307             589 707         1.26164   2.93281   3.70743   4.17665   0.00407
  8                15H18           46XY               100            1 548 855             589 173         1.27874   3.07974   3.94434   2.16982   0.12560
  9               17HCGY           46XY               100             749 354              309 033         1.27818   3.04466   3.87758   2.12275   0.12264
  10               19H2            46XY               100            1 929 900             744 124         1.30932   3.08860   3.90929   2.21683   0.12699
  11               21H4            46XX               100            3 285 106            1 244 513        1.26613   2.97819   3.82873   4.29276   0.00410
  12               25H9            46XY               100            1 575,322             667 903         1.32747   3.00182   3.86819   2.16540   0.12929
  13               27H1            46XX               100             947 196              377 647         1.27924   2.91754   3.67009   4.09139   0.02304
  14               31H6            46XY               100            1 248 950             476 205         1.29776   2.98863   3.57304   2.05458   0.13776
  15               32H7            46XY               100             693 356              268 692         1.34987   2.88137   3.58328   2.01383   0.12840
  16               33H8            46XY               100             929 156              371 080         1.31239   2.99262   3.70971   2.05805   0.13825
  17               34H9            46XY               100            1 647 104             646 180         1.30010   2.94190   3.62840   2.01244   0.13263
  18               40H6            46XX               100             728 707              278 944         1.26190   2.88158   3.41323   4.01586   0.01972
  19               42H8            46XY               100            2 021 819             829 302         1.29856   3.00795   3.82840   2.08272   0.13578
  20               43H9            46XX               100             685 181              270 538         1.27967   2.90236   3.52557   4.06486   0.02735
  21               44H10           46XY               100             993 450              400 726         1.30688   3.00180   3.72499   2.09894   0.13550
  22               45H11           46XY               100             636 527              250 931         1.30315   2.93308   3.64762   2.08464   0.13709
  23               46H12           46XY               100            1 010 133             399 849         1.30249   2.96512   3.72216   2.09129   0.14480
  24               47H13           46XY               100             764 726              301 493         1.28494   2.95828   3.58284   2.08827   0.13466
  25               48H1            46XY               100            3 003 505            1 149 789        1.29728   3.03621   3.86358   2.27746   0.11976
  26               54H7            46XY               100            1 561 427             589 196         1.29923   3.03974   3.85305   2.12900   0.12424
  27               56H9            46XX               100            2 322 635             885 707         1.27119   2.98022   3.78613   4.21618   0.00339
  28               57H10           46XX               100            1 278 926             512 310         1.29219   2.89961   3.57791   4.06414   0.02264
  29               60H14           46XY               100            1 618 924             616 422         1.26456   3.06495   3.95038   2.13555   0.12475
  30               62H16           46XY               100             661 358              263 458         1.30875   2.89420   3.73532   2.17530   0.12791
  31              61HWMH          47XX+21             100             833 041              340 693         1.85651   2.98157   3.71009   4.05644   0.01967
  32              72HT21          47XY+21             100             766 103              311 852         1.93585   3.01072   3.82617   2.13627   0.12955
  33               74H3           47XX+21             100            1 127 241             458 743         1.91087   2.81705   3.54033   4.03080   0.02180
  34              81HWMH          47XX+21             100             650 242              273 303         1.73434   2.77714   3.39257   3.96812   0.02378
  35               02H2           47XY+18             90             1 091 649             429 544         1.28206   4.39862   3.64852   2.05544   0.12828
  36               06H7           47XY+18             100            1 851 667             706 651         1.26689   4.54298   3.71881   2.10174   0.12198
  37              82HCXP          47XY+18             100             503 179              204 295         1.27707   4.42742   3.78815   1.99858   0.11601
  38               04H4            46XY               100            1 754 104             666 002         1.29819   2.94188   3.67957   2.12507   0.11662
  39               05H6            46XX               100            2 434 717             898 966         1.27680   2.90456   3.57889   4.13297   0.00389
  40               63H17           46XY              90.8             685 313              275 177         1.30970   2.98680   3.86915   2.04850   0.14064
  41               65H4            46XY               100            1 202 799             473 140         1.32244   2.97185   3.70208   2.07402   0.14879
  42               66H9            46XX               100            1 623 201             617 337         1.27888   2.96166   3.83680   4.27724   0.00340
  43               67H10           46XX               100             811 894              327 382         1.28443   2.85660   3.64566   4.10071   0.02474
  44               68H11           46XY               100            6 381 643            2 455 268        1.29619   3.07979   3.96616   2.15150   0.12931
  45               69H12           46XX               100             955 289              384 784         1.28384   2.93281   3.62723   4.14050   0.02339
  46               70H13           46XX               100             833 449              328 863         1.25554   2.91215   3.66147   4.13212   0.02037
  47               71H14           46XX               100            1 321 322             523 536         1.29943   2.87430   3.56537   4.04327   0.02636
  48               73H2            46XY               100             705 325              277 705         1.32443   2.94017   3.72230   2.07342   0.12639
  49               77H8            46XX               100             664 485              271 294         1.28422   2.95805   3.74686   4.10035   0.02101
  50              83HSHD           46XX               100             551 560              223 988         1.26480   2.93632   3.66657   4.01227   0.02411
  51               07H8            46XY               100            1 383 844             525 106         1.28203   3.06243   3.92035   2.23364   0.12950
  52              94HLCH           46XY               100             888 892              509 386         1.29097   3.02639   3.87113   2.17399   0.11661
  53              95HSCJ           46XX               100             863 603              498 346         1.26719   2.93932   3.74920   4.13408   0.00301
  54              96HLLR           45XO               100             880 178              508 298         1.29727   3.02775   3.67776   2.11766   0.00315
  55               97HHH           45XO               100             984 935              565 960         1.29161   2.99420   3.87572   2.17719   0.00166
  56              98HMCM          47XX+21             100             525 892              303 307         1.89610   2.89344   3.47536   4.10475   0.00396
  57              99HZQL           46XX               100             898 477              518 330         1.29705   2.98664   3.77655   4.19713   0.00251
  58              118AXCR          46XX               99             1 132 088             440 245         1.27406   3.04603   3.82810   2.14335   0.12402
  59              121ASSH         47XY+21             100            1 045 028             394 985         1.93628   3.02847   3.72698   2.07983   0.12557
  60              125A22           46XX               100            1 217 046             469 095         1.26350   3.03755   3.79454   4.22857   0.00384
  61              126AJYJ         47XY+18             100            1 207 389             471 223         1.22044   4.51952   3.77189   2.11895   0.11948
  62              129AGJ          47XX+18             100            1 181 077             449 114         1.25358   4.37083   3.69461   4.20539   0.00178

Normalized UR% values for all 22 autosomes and chromosome X were calculated ([Fig. 3](#pone-0027835-g003){ref-type="fig"}). 5 cases of trisomy 18, 6 cases of trisomy 21 and 2 cases of XO were successfully detected in the cohort of 32 test cases, which presented 100% of sensitivity and 100% of specificity.

![The normalized UR% value per chromosome between different samples.\
11 trisomy samples have a normalized UR% value of 1.5 and 2 cases of 45 XO have a normalized UR% value of 0.5.](pone.0027835.g003){#pone-0027835-g003}

Detection of imbalanced chromosomal arrangements {#s2b}
------------------------------------------------

To further validated our developed and optimized analysis method among cases with imbalanced chromosomal arrangements, we obtained 44∼70 M sequence tags for the 5 "known" samples with 1.4 to 2.3× whole genome depth. To detect segmental copy number variations, a sequence-based Matlab CNV detection package, SegSeq, with YH reference genome as comparative genome were used. By applying the SegSeq analysis, we detected microdeletions and microduplications in all 5 samples ([Table 2](#pone-0027835-t002){ref-type="table"}). All the 5 chromosomal copy number variations ranged from 1.4 Mb to 37.3 Mb were validated by arrayCGH and were mapped precisely to the correct location. Four pregnancies were terminated after genetic detection and only one pregnant gave a live birth ([Table S3](#pone.0027835.s003){ref-type="supplementary-material"}).

10.1371/journal.pone.0027835.t002

###### Pathogenic chromosomal copy number changes and imbalance rearrangements identified by SeqSeq analysis which have been validated by arrayCGH.

![](pone.0027835.t002){#pone-0027835-t002-2}

  Array No.              Karyotype                                                     arrayCGH                                                                                  Segseq
  ----------- -------------------------------- ----------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------
  A10071659                46,XY                                     deletion at 13q32.3q33.3(97091318∼106466788)                                             deletion at chr13: 97075576∼106516365(9.4 M)
  A10021390    46,XY,der(5)t(5;18)(p13;q12.3)   deletion at 5p15.3∼p13.2(183931∼36816731);duplication at 18p12.3∼q23(39086755∼76067279)   deletion at chr5: 1∼36861739(36.9 M);duplication at chr18: 38768509∼76117152(37.3 M)
  A10021383              46,XY,2q+                                  duplication at 2q36∼q37.3(230369496∼242444380)                                          duplication at chr2: 230288772∼242427293(12.1 M)
  A11091844                46,XX                                         deletion at 3q29(197216353∼198770242)                                                deletion at chr3: 197372027∼198831453(1.4 M)
  A10071710                46,XY                                        deletion at 22q11.21(17289032∼19636115)                                               deletion at chr22: 17396815∼20248184(2.8 M)

Two samples (A10021383, A10071659) were selected to further ascertain the results on the HumanOmni2.5 M chip (Illumina). CNV partition Algorithm plug-in, was used to detect copy number variations in these two samples. A duplication at 2q36∼q37.3 (230369496∼242444380) and a deletion at 13q32.3q33.3 (97091318∼106462788) were correctly detected, totally in concordance with the arrayCGH and sequencing analysis results.

Discussion {#s3}
==========

Massively parallel sequencing has been reported only to apply in noninvasive prenatal diagnosis of trisomy 21, 18 and 13 based on cell-free fetal DNA, due to it is limited amount of fragmented fetal DNA [@pone.0027835-Ehrich1]. This also makes noninvasive MPS-based prenatal diagnosis difficult to detect all the chromosomal aneuploidies and the sexual chromosome abnormality accurately. In this study, we demonstrated for the first time that combined MPS with powerful bioinformatics analysis method can accurately diagnosis fetal aneuploidy and imbalanced chromosomal structural abnormalities. In fact, this study reports the first retrospective use of MPS (so called next generation sequencing) for prenatal diagnostics of chromosomal imbalance rearrangements to date and shows that it is practically feasible on a large-scale prenatal diagnosis of fetal chromosomal abnormalities.

By establishing a normal control sequencing tag data set, we have been able to demonstrate this new approach only requires a minimum among of DNA materials (100 ng) to achieve the identification of aneuploidies with a ultra low sequencing coverage (0.01×). Comparing to the golden standard (G-Band karyotyping) in clinical practice, MPS has no time limitation. Also as long as 100 ng genomic DNA can be extracted from tissues at any gestational weeks, MPS can be performed and report all fetal aneuploidies in 7 days. If necessary, more sequence reads can be performed to detect whether microdeletion or microduplication exists in the fetal genome which may result in severe developmental retardation. In our study, tissues obtained from fetus, such as amniotic fluid, CVS and placenta can be analyzed without cell culture since 100 ng genomic DNA is sufficient for library preparation and sequencing. So it can be used for the research into the molecular mechanism of miscarriage, stillbirth and fetal death when tissues are difficult to culture. Furthermore, our validation study on the 5 arrayCGH samples show that when more sophisticated sequencing protocols and bioinformatics algorithms are applied to the analysis, it is possible to detect smaller size chromosomal copy number variations as well as complex rearrangements across the whole genome of the fetus, such as balanced chromosomal arrangements,structure variations or even single-gene disorders. With the application of third-generation sequencing system in clinical laboratories, such as Miseq/Illumina and Ion Torrent PGM/Life Technologies, the whole process will take less time and acceptable price. Thus, it is likely that MPS will play an increasingly important role in the future development of prenatal screening and diagnosis.

A potential weakness of the study was that in the figure of describing the ratio of unique reads in each chromosome, chromosome19 and 22 have a differently huge coefficient of variation because of their extremely high GC content and made the detection of trisomy19 and trisomy22 difficult. Further study will be set up to deal with these problems, for example the computational correction of GC content among chromosomes. Other chromosomal abnormalities, such as balanced translocation or incomplete aneuploidy caused by mosaics or partial duplication or deletion of a chromosome should, in principle, also be detectable. Further studies are required to determine the effectiveness of massively parallel genomic sequencing in detecting these rare aberrations. Another weakness for the new methodology was the starting materials for library construction; with the conventional Illumina library construction approach100 ng genomic DNA of fetus was required. To further reduce the risk to pregnancies it would be important to reduce the amount for AF or CVS samples, other library construction methods such as using in vitro transposition may be an alternative solution.

In conclusion, we have demonstrated the usefulness of massively parallel sequencing to detect fetal aneuploidy and imbalanced chromosomal abnormalities of genomic DNA in prenatal samples. In principle, massively parallel sequencing can also reveal other features of the genomic material from amniotic fluid such as histone modifications as well as epigenetic DNA methylation. With the rapid reduction of sequencing cost, we expect that the strategy described in this article will become a powerful tool in the detection of all kinds of chromosomal abnormalities in clinical settings.

Materials and Methods {#s4}
=====================

Subject Enrollment and Sample Recruitment {#s4a}
-----------------------------------------

The study was approved by the Institutional Review Board of Beijing Obstetrics and Gynecology hospital of the Capital Medical University. Informed consent was obtained from each participant.

A total of 32 pregnant women at a high risk of Down\'s syndrome were recruited as test cases from the Beijing Obstetrics and Gynecology hospital during the period of January to May 2010. Amniocentesis was applied at 19∼22th gestational week and standard G-band karyotyping analysis was performed. Another 30 euploid AF samples (20 with male fetus and 10 with female fetus) were included as normal control at the same hospital. To validate the sensitivity of analysis method for detection of microdeletion/microduplication, 5 chorionic villus sampling (CVS) samples validated by karyotyping and arrayCGH were recruited from the Prenatal Genetic Diagnosis Centre (PGDC) at Department of Obstetrics & Gynecology, Chinese University of Hong Kong.

Sample Preparation and Sequencing {#s4b}
---------------------------------

Genomic DNA was extracted from uncultured AF samples with Micro DNA Kit (Tiangen) and quantified with the Quant-iT dsDNA HS Assay Kit (Invitrogen). 100 ng genomic DNA from each sample was sheared into small fragments ranged from 100 to 400 bp with Bioruptor (Diagenode). After end-repair, "A"- overhanging and adapter-ligation, DNA fragments of 300 bp (±25 bp) in length were selected by 2% agarose gel electrophoresis and underwent 12 cycles of PCR with multiplex primers. PCR products were purified by Agencourt AMPure Kit (Beckman). Size distribution of the library was detected by Agilent Bioanalyzer DNA 1000 kit (Agilent Technologies) and the concentration was measured by quantitative PCR (qPCR). Libraries with different index tags were mixed in equal moles into a pool and sequenced with single-end 36 cycle multiplex sequencing on Illumina GAIIx platform.

For the 5 DNA samples from CVS tissues, sequencing libraries with the insert size of 500 bp (±25 bp) were prepared. Paired-end 100 cycle multiplex sequencing was performed on Illumina HiSeq 2000.

Bioinformatics analysis {#s4c}
-----------------------

### *z-score* for detection of fetal aneuploidy {#s4c1}

35-bp single-end reads from 62 AF samples (30 normal controls and 32 test cases) were aligned against repeat-masked human genome build 36 (hg18) by ELAND. Unique reads (UR), which can be mapped to reference genome sequence without any mismatches or alternative positions, were used for further analysis. The UR percentage (UR%) of chromosome N (UR-N%, N denotes chromosome number) can be used as an indicator of fetal trisomy for autosomes. To satisfy central-limit theorem, 30 euploid samples were used as normal controls. The *z-score* of chromosome N (N stands for chromosome numbers) is calculated as,For autosomes, considering about the type I error rate (α) of 0.01, 3 was set as a cut-off value to determine the fetal trisomy.

### SegSeq algorithm for detection of microdeletion/microduplication {#s4c2}

We mapped the Illumina reads to the reference sequence of human genome (HG18, NCBI 36.3) by Short Oligonucleotide Analysis Package aligner (SOAP2) (<http://soap.genomics.org.cn/>) [@pone.0027835-Li1] with parameter about total allowed mismatches (-v 5), seed length (-s 40), minimal aligning length (-l 40) and insert DNA size enabled. Only unique reads were remained in following CNV analysis.

For the CNV detection, we employed a MATLAB packet, SegSeq (<http://www.broadinstitute.org/cgi-bin/cancer/publications/pub_paper.cgi?mode=view&paper_id=182>) [@pone.0027835-Chiang1], with YH Illumina reads [@pone.0027835-Wang1] as reference control. Segments with copy ratio, calculated by SegSeq, less than 0.75 or greater than 1.25 were reported as variations. CNVs on critical regions of identified diseases would be an important signal for clinical screening/diagnose.

### CNV Detection by arrayCGH and SNP typing array {#s4c3}

Genomic chromosomal copy number variants (CNVs) were detected using a targeted high resolution 44 K oligonucleotide array specifically constructed for prenatal screening with the intention of targeting common trisomic aneuploidies and most known microdeletion and microduplication syndromes. This Fetal DNA chip included telomeric and pericentromeric regions, examining the genome to a resolution of 100 kb (<http://www.fetalmedicine.hk/en/Fetal_DNA_Chip.asp>) [@pone.0027835-Leung2]. The Fetal DNA chip is specially (<http://www.fetalmedicine.hk/en/Fetal_DNA_chip/Appendix_I.pdf>) with most of the known common non-pathogenic CNVs regions removed. This chip provides a means to detect chromosomal aberrations with resolution of \<100 Kb across the genome. The quality of the array was analysed using Agilent DNA analytics software and cases where the Derivative Log Ratio spread of the array was \>0.25 were excluded from further data analysis. Data reporting variations in copy number were released after excluding known non-pathogenic chromosome copy number variants that have been listed at the Database of Genomic Variants.

To ascertain the accuracy of MSP-based CNV detection method, two CVS samples were analyzed with HumanOmni2.5-Quad Bead Chip according to Illumina manufacturer\'s protocol and CNV partition plug-in software was employed for DNA copy number analysis.
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